Interview with Colossal Biosciences CEO Ben Lamm on De-extinction and AI

Ben Lamm, CEO of Colossal Biosciences, discusses the company's de-extinction projects, including the dire wolf, woolly mammoth, and dodo, and the AI platform GenomeMorph. The conversation explores the scientific challenges, ethical considerations, and business strategy behind these efforts.

■ De-extinction Projects and Science
- Overview of Colossal's work on dire wolf, woolly mammoth, dodo, and Tasmanian tiger
- Challenges in genome engineering and managing a product-focused company
- Use of ancient DNA and comparative genomics

■ AI Platform and Technology
- Development and purpose of GenomeMorph AI platform
- Identifying genetic targets for de-extinction
- Applications and potential open-source release

■ Ethics, Conservation, and Business
- Collaboration with governments, indigenous groups, and conservation organizations
- Discussion of environmental impact and biodiversity crisis
- Business model and future plans, including potential IPO

This video is suitable for those interested in biotechnology, de-extinction, AI in science, conservation, and the business aspects of biotech startups. Viewers will gain insights into the scientific and ethical challenges of de-extinction, the role of AI in genomics, and the commercial potential of synthetic biology platforms.